The MEA Biomaterials Market Size was valued at USD 7.85 billion in 2024. The MEA Biomaterials Market Size is expected to have 12.66 % CAGR from 2025 to 2033 and be worth USD 22.96 billion by 2033 from USD 8.84 billion in 2025.
The use of medical plastic, stainless steel /titanium metal replacement implant materials for medical purposes is being affected by biocompatibility issues, in addition to the demand for superior implant mechanical performance. For this, the manufacturers are looking towards more effective and companionable materials.
Increased use of biomaterials is mainly attributed to the research efforts in medical technology for the efficient functionality of medical implants.
In addition, an increase in government funding and the availability of new technologies such as hydrogen scaffolding and decellularized dermal matrixes for grafting are some of the factors driving the growth of the Middle-East & African biomaterials market. Furthermore, due to the increasing number of geriatric patients, the demand for the usage of biomaterials in cardiology, wound healing, neurology, and plastic surgery is also on the rise. Besides, it will contribute to the market is growing at a healthy rate throughout the forecast period.However, adverse reactions to biomaterial implants, inflammation and fracture issues, high cost associated with, and difficulties in manufacturing are the major factors off-putting the growth of the Middle-East & African biomaterials market.
REPORT METRIC |
DETAILS |
Market Size Available |
2024 to 2033 |
Base Year |
2024 |
Forecast Period |
2025 to 2033 |
CAGR |
12.66 % |
Segments Covered |
By Material Type, Application and Country. |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Country Covered |
KSA ,UAE ,Israel ,rest of GCC countries, South Africa ,Ethiopia ,Kenya ,Egypt, Sudan, Rest of MEA. |
Market Leader Profiled |
Royal DSM, Zimmer Biomet Holdings, Inc., Wright Medical Technology, Inc. |
Some of the key players in the Middle-East & Africa biomaterials market include Royal DSM, Zimmer Biomet Holdings, Inc., Wright Medical Technology, Inc., Corbion N.V., Berkeley Advanced Biomaterials, Bayer AG, Carpenter Technology Corporation, Evonik Industries AG, Covalon Technologies Ltd., BASF SE, Invibio Ltd., Inc., CAM Bioceramics BV, and Collagen Matrix, Inc.While existing players operating in the Middle East & Africa are trying to expand their product portfolio and increase growth, few companies are trying to enter the market through acquisitions to capitalize on the growing opportunities.
This research report on the mea biomaterials market has been segmented and sub-segmented the Europea biomaterials market into the following categories
By Material Type
By Application
By Country
Frequently Asked Questions
Key drivers include the growing geriatric population, increased prevalence of chronic diseases, advancements in biomaterial technologies, rising demand for orthopedic and dental implants, and increasing government healthcare investments.
The MEA Biomaterials Market refers to the industry focused on developing, manufacturing, and distributing natural or synthetic materials used in medical applications like implants, tissue engineering, and drug delivery across Middle Eastern and African countries.
The major contributors are Saudi Arabia, UAE, South Africa, Egypt, and Israel due to their advanced healthcare infrastructure and increasing adoption of modern medical technologies.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region